Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DCB has enabled the advancement of multiple new drug candidates through preclinical stages into clinical pipelines via partnerships or spin-offs. It plays a pivotal role in Taiwan’s biotech ecosystem by bridging academic discoveries with industry commercialization through technology transfer agreements and strategic alliances. Recent collaborations include AI-powered drug discovery initiatives targeting oncology and immunotherapy using advanced computational platforms like those developed with Vizuro LLC.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Development Center for Biotechnology.